News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence
Braxia Scientific Corp.
Core One Labs Completes Audit, Starts Review of Ops
Core One Labs Inc.
Mydecine Innovations Group Announces Extended Lock-Up Arrangement
Mydecine Innovations Group
MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD
Mind Medicine (MindMed)
Dr. Joseph Tucker | Gründer und CEO von MagicMed Industries
Enveric Biosciences
ATAI Life Sciences Launches EmpathBio To Treat Post-Traumatic Stress Disorder With Novel MDMA Product
ATAI Life Sciences
Field Trip Psychedelics Inc. Announces Closing of $11.0 million Financing, Entry into Amalgamation Agreement with Newton Energy Corporation
Field Trip Health
Dr. Joseph Tucker | Founder & CEO, MagicMed Industries
Enveric Biosciences
Irie Selkirk | Co-Founder, Rise Wellness Retreat
GoodCap Wellness
ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines
ATAI Life Sciences
NeonMind Ready to Launch Four Mushroom Coffee Blends
NeonMind Biosciences Inc.
Core One Labs Appoints New Chief Financial Officer
Core One Labs Inc.
Mydecine Innovations Group Adds Dr. Robin Carhart-Harris and Dr. David Erritzoe to Scientific Advisory Board
Mydecine Innovations Group
Mydecine™ Launches World's First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
Mydecine Innovations Group
Garyn Angel | Founder & CEO, Magical Brands
Magical Brands
Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results
Mind Medicine (MindMed)
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.